Seeing Is Believing
Currently out of the existing stock ratings of Nathan Weinstein, 33 are a BUY (94.29%), 2 are a HOLD (5.71%).
Analyst Nathan Weinstein works at AEGIS with a stock forecast success ratio of 8.33% fulfilled within 20.07 days on average.
Nathan Weinstein’s has documented 63 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EVGN, Evogene at 12-Sep-2022.
Analyst best performing recommendations are on ORMP (ORAMED PHARMACEUTICALS).
The best stock recommendation documented was for ORMP (ORAMED PHARMACEUTICALS) at 6/8/2021. The price target of $20 was fulfilled within 62 days with a profit of $6.15 (44.4%) receiving and performance score of 7.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
20
$18.21 (1017.32%)
1 days ago
0/3 (0%)
$18.21 (1017.32%)
Buy
9
$7.21 (402.79%)
10 months 16 days ago
0/3 (0%)
$7.1 (373.68%)
Buy
1 years 1 days ago
0/1 (0%)
$17.08 (114.48%)
Buy
28
1 years 11 months 27 days ago
0/2 (0%)
$16.83 (150.67%)
Hold
9
$7.21 (402.79%)
17
1 years 11 months 26 days ago
0/3 (0%)
$3.91 (76.82%)
What Year was the first public recommendation made by Nathan Weinstein?